No Data
No Data
No Data
No Data
No Data
On April 26, Heyu-B (02256) spent about HK$472,400 to buy back 149,000 shares
Goodwill B (02256) announced that on April 26, 2024, it cost approximately HK$472,400 to buy back 14.9...
Zhitong FinanceApr 26 10:17 ET
Abbisko Cayman's Liver Cancer Drug Gets US FDA Orphan Drug Designation
The US Food and Drug Administration granted orphan drug designation to Abbisko Cayman's (HKG:2256) irpagratinib medication for hepatocellular carcinoma or liver cancer, according to a Thursday filing
MT NewswiresApr 25 05:14 ET
Goodwill B (02256): The FGFR4 inhibitor ipagotinib was certified as an orphan drug by the US FDA
Heyu-B (02256) issued an announcement. The company's subsidiary, Shanghai Heyu Biomedical Technology Co., Ltd. (Heyu...
Zhitong FinanceApr 24 19:47 ET
Goodwill B (02256.HK) spent HK$156,000 to buy back 51,000 shares on April 24
On April 24, Gelonghui (02256.HK) announced that it spent HK$156,000 to buy back 51,000 shares on April 24.
Gelonghui FinanceApr 24 10:10 ET
Goodwill B (02256): Tian Huimin resigns as joint company secretary
Zhitong Finance App News, Heyu-B (02256) issued an announcement. Due to the need to invest more energy in other jobs, Tian Huimin has resigned as the company's co-company secretary, effective April 24, 2024.
Zhitong FinanceApr 24 08:52 ET
Goodwill B (02256) spent HK$1,536,000 to buy back 500,000 shares on April 23
Heyu-B (02256) issued an announcement to repurchase 5 at HK$1,536,000 on April 23, 2024...
Zhitong FinanceApr 23 08:23 ET
No Data
No Data